Document 0682 DOCN M94A0682 TI Incidence of HBV and HCV in prison entrants in Victoria, 1991-92: evidence of a core risk group for HIV transmission. DT 9412 AU Crofts N; Stewart T; Hearne P; Breschkin A; Locarnini S; Macfarlane Burnet Centre, Fairfield, Vic. SO Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:41 (abstract no. TE7). Unique Identifier : AIDSLINE ASHM5/94348973 AB AIM: To measure incidence of blood-borne viruses among prison entrants, to assess risk in these populations for HIV transmission. METHODS: All entrants to Pentridge Prison between Oct91 and Oct92 were tested with consent for HIV/HBV/HCV; incidence rates were calculated for those tested more than once in the period. Limited demographic and risk behaviour data were collected. RESULTS: 350 people were tested more than once in the study period. The seroconversion rate for HBV was 12.5% p.a., and for HCV was 18.3% p.a. Seroconverters (sc's) for both viruses were all males aged less than 30 years (mean 22.5 years, sd 3.5) who gave a history of injecting drug use IDU); among this group, seroconversion rates were 26% and 41% p.a. respectively. 90% of the HBV sc's were anti-HCV positive, and 80% of the HCV sc's were anti-HBV core negative at first bleed. None of the seroconverters was HIV positive, and none of the 0.5% of entrants who were anti-HIV positive was retested in the study period; they were all male, but older (mean 31.2 years, sd 4.3) and less likely to have a history of IDU. CONCLUSIONS: Blood-borne viruses are spreading freely in this population, especially among male IDUs aged less than 30, who make up 30% of all prison entrants in Victoria. Given previous findings that HBV is a good surrogate marker for HIV risk in IDU populations, it is possible that we have identified a core group at high risk for HIV if it were to enter this population. DE Adult Cross-Sectional Studies Hepatitis B/*EPIDEMIOLOGY/TRANSMISSION Hepatitis C/*EPIDEMIOLOGY/TRANSMISSION Human HIV Infections/EPIDEMIOLOGY/*TRANSMISSION Incidence Male Prisoners/*STATISTICS & NUMER DATA Risk Factors Substance Abuse, Intravenous/COMPLICATIONS/EPIDEMIOLOGY Victoria/EPIDEMIOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).